MedTrace Logo

Efficacy, Safety, and Pharmacokinetics of Intravenous Ibuprofen in Adult Febrile Patients

NCT01131000 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 123

Last updated 2010-05-26

No results posted yet for this study

Summary

The primary objective of this study is to evaluate the efficacy of intravenous ibuprofen on reducing fever at 4 hours.

Conditions

Interventions

DRUG

Ibuprofen

Intravenous ibuprofen, 100 mg, Single-dose

DRUG

Ibuprofen

Intravenous ibuprofen, 200mg, single dose

DRUG

Ibuprofen

Intravenous ibuprofen, 400 mg, Single-dose

OTHER

Normal Saline

Normal Saline, 100 ml, Single-dose

Sponsors & Collaborators

  • Cumberland Pharmaceuticals

    lead INDUSTRY

Principal Investigators

  • Gordon Bernard, M.D. · Cumberland Pharmaceuticals, Inc.

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2002-06-30
Primary Completion
2005-08-31
Completion
2005-08-31

Countries

  • United States
  • Australia
  • Thailand

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01131000 on ClinicalTrials.gov